Literature DB >> 10782016

Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population.

P Menounos1, C Zervas, G Garinis, C Doukas, D Kolokithopoulos, C Tegos, G P Patrinos.   

Abstract

We report results from a systematic study to identify the molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency on a sample of 299 male subjects from the Hellenic population. Our stepwise approach involved partial biochemical characterization and quantitation of the enzyme's activity, MboII restriction endonuclease digestion to identify the G6PD Mediterranean variant, which represents the most frequent G6PD variant in our population and a nonradioactive polymerase chain reaction-single-strand conformation polymorphism methodology for the detection of the underlying molecular defect(s) in the rest of the non-Mediterranean G6PD-deficient individuals. Through this approach, six different G6PD variants were identified (G6PD Mediterranean, G6PD Hermoupolis, G6PD Cassano, G6PD Seattle, G6PD Ierapetra and G6PD Acrokorinthos), two of which were new (G6PD Hermoupolis, G6PD Acrokorinthos). In essence, this study underlines the remarkable genetic heterogeneity of the G6PD deficiency in the Hellenic population, while the finding of the double mutant, G6PD Hermoupolis, may help to outline the relationship and evolution of mutations in the human G6PD locus. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782016     DOI: 10.1159/000022922

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  9 in total

1.  Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.

Authors:  Marin Barišić; Jelena Korać; Ivana Pavlinac; Vjekoslav Krželj; Eugenija Marušić; Tom Vulliamy; Janoš Terzić
Journal:  J Hum Genet       Date:  2005-09-06       Impact factor: 3.172

2.  Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.

Authors:  Nguyen Thi Hue; Jean Paul Charlieu; Tran Thi Hong Chau; Nick Day; Jeremy J Farrar; Tran Tinh Hien; Sarah J Dunstan
Journal:  Malar J       Date:  2009-07-10       Impact factor: 2.979

3.  Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq.

Authors:  Nasir Al-Allawi; Adil A Eissa; Jaladet Ms Jubrael; Shakir Ar Jamal; Hanan Hamamy
Journal:  BMC Blood Disord       Date:  2010-07-05

4.  Glucose-6-phosphate dehydrogenase deficiency does not result from mutations in the promoter region of the G6PD gene.

Authors:  Panayiotis G Menounos; George A Garinis; George P Patrinos
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq.

Authors:  Bassam Ms Al-Musawi; Nasir Al-Allawi; Ban A Abdul-Majeed; Adil A Eissa; Jaladet Ms Jubrael; Hanan Hamamy
Journal:  BMC Blood Disord       Date:  2012-03-27

6.  Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.

Authors:  Germana Bancone; Cindy S Chu; Raweewan Somsakchaicharoen; Nongnud Chowwiwat; Daniel M Parker; Prakaykaew Charunwatthana; Nicholas J White; François H Nosten
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

7.  Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.

Authors:  Marcela Vela-Amieva; Miguel Angel Alcántara-Ortigoza; Ariadna González-Del Angel; Leticia Belmont-Martínez; Carlos López-Candiani; Isabel Ibarra-González
Journal:  Orphanet J Rare Dis       Date:  2021-02-26       Impact factor: 4.123

Review 8.  G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.

Authors:  Germana Bancone; Cindy S Chu
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

9.  Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation.

Authors:  Naif S Karadsheh; Nisreen A Quttaineh; Salem N Karadsheh; Mohammad El-Khateeb
Journal:  BMC Endocr Disord       Date:  2021-12-23       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.